Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Currently submitted to: JMIR Research Protocols

Date Submitted: Jul 4, 2019
Open Peer Review Period: Jul 8, 2019 - Jul 22, 2019
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note “no longer under consideration” will appear above).

Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a “Peer-Review Me” button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed “version of record” (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Outcomes of Patients’ Evidence with Novel, Do-it-Yourself Artificial Pancreas Technology (OPEN): How Academia, Industry and Patient Innovators Can Reduce the Burden of Diabetes - Together

  • Shane O'Donnell; 
  • Dana Lewis; 
  • María Marchante; 
  • Mandy Wäldchen; 
  • Bryan Cleal; 
  • Timothy Skinner; 
  • Klemens Raile; 
  • Adrian Tappe; 
  • Ingrid Willaing; 
  • Bastian Hauck; 
  • Saskia Wolf; 
  • Ciarán Mahony; 
  • Tebbe Ubben; 
  • Katarina Braune; 

ABSTRACT

Background:

Digital innovations in healthcare have traditionally followed a top-down pathway, with manufacturers leading the design and production of technology-enabled solutions and those living with chronic conditions involved only as passive recipients of the end-product. However, user driven open source initiatives in healthcare are becoming increasingly popular. A leading example is the growing movement of people with diabetes, who create their own “Do-it-Yourself Artificial Pancreas Systems” (DIYAPS).

Objective:

The overall aim of this project is to build empirical evidence on the DIYAPS movement and to investigate its outcomes, as well as challenges and implications for its wider diffusion.

Methods:

A research program consisting of 5 work packages will examine the outcomes and potential for scaling up DIYAPS solutions. Quantitative and qualitative techniques will be used in order to examine clinical and patient-reported outcome measures of DIYAPS. The majority of the research team live with type 1 diabetes and are active DIYAPS users, making OPEN a uniquely user-driven research project.

Results:

This project has received funding from the European Commission's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie Action Research and Innovation Staff Exchange (RISE). Researchers with both academic and non-academic backgrounds have been recruited to formulate research questions, drive the research process and disseminate ongoing findings back to the DIYAPS community and other stakeholders.

Conclusions:

The OPEN project is unique in that it is a truly patient/user-led research project bringing together an international, interdisciplinary and intersectoral research group consisting of healthcare professionals, technical developers, biomedical and social scientists, the majority of whom also living with diabetes. Thus it directly addresses the core research but also user needs of the DIYAPS movement. The result will be a new model for co-creation that will highlight how researchers in academia, industry and the patient user space can create patient-centric innovation and reduce disease burden together.


 Citation

Please cite as:

O'Donnell S, Lewis D, Marchante M, Wäldchen M, Cleal B, Skinner T, Raile K, Tappe A, Willaing I, Hauck B, Wolf S, Mahony C, Ubben T, Braune K

Outcomes of Patients’ Evidence with Novel, Do-it-Yourself Artificial Pancreas Technology (OPEN): How Academia, Industry and Patient Innovators Can Reduce the Burden of Diabetes - Together

JMIR Preprints. 04/07/2019:15368

DOI: 10.2196/preprints.15368

URL: https://preprints.jmir.org/preprint/15368


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.